文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Discovery of an evodiamine derivative for PI3K/AKT/GSK3β pathway activation and AD pathology improvement in mouse models.

作者信息

Pang Shuo, Li Siyuan, Cheng Hanzeng, Luo Zhuohui, Qi Xiaolong, Guan Feifei, Dong Wei, Gao Shan, Liu Ning, Gao Xiang, Pan Shuo, Zhang Xu, Zhang Li, Yang Yajun, Zhang Lianfeng

机构信息

Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Beijing Engineering Research Center for Experimental Animal Models of Human Diseases, Institute of Laboratory Animal Science, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

出版信息

Front Mol Neurosci. 2023 Jan 9;15:1025066. doi: 10.3389/fnmol.2022.1025066. eCollection 2022.


DOI:10.3389/fnmol.2022.1025066
PMID:36698780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9868638/
Abstract

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive neurodegeneration and cognitive decline. Evodiamine, a main component in Chinese medicine, was found to improve cognitive impairment in AD model mice based on several intensive studies. However, evodiamine has high cytotoxicity and poor bioactivity. In this study, several evodiamine derivatives were synthesized heterocyclic substitution and amide introduction and screened for cytotoxicity and antioxidant capacity. Under the same concentrations, compound was found to exhibit lower cytotoxicity and higher activity against HO and amyloid β oligomers (AβOs) than evodiamine and significantly improve the working memory and spatial memory of 3 x Tg and APP/PS1 AD mice. Subsequent RNA sequencing and pathway enrichment analysis showed that affected AD-related genes and the AMPK and insulin signaling pathways. Furthermore, we confirmed that recovered PI3K/AKT/GSK3β/Tau dysfunction and . In conclusion, represents a potential lead compound for AD therapy based on the recovery of PI3K/AKT/GSK3β pathway dysfunction.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/02247c8410f5/fnmol-15-1025066-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/f71d5747c4e2/fnmol-15-1025066-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/ecf0d8c3b43a/fnmol-15-1025066-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/2e42de2a5611/fnmol-15-1025066-g0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/3f2e017ba3a9/fnmol-15-1025066-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/7e37164a363b/fnmol-15-1025066-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/d5aa184ec988/fnmol-15-1025066-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/8c93a93df9bd/fnmol-15-1025066-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/722374caf230/fnmol-15-1025066-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/e96b95058ae2/fnmol-15-1025066-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/ce277adb715e/fnmol-15-1025066-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/fcafdce34d72/fnmol-15-1025066-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/02247c8410f5/fnmol-15-1025066-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/f71d5747c4e2/fnmol-15-1025066-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/ecf0d8c3b43a/fnmol-15-1025066-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/2e42de2a5611/fnmol-15-1025066-g0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/3f2e017ba3a9/fnmol-15-1025066-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/7e37164a363b/fnmol-15-1025066-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/d5aa184ec988/fnmol-15-1025066-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/8c93a93df9bd/fnmol-15-1025066-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/722374caf230/fnmol-15-1025066-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/e96b95058ae2/fnmol-15-1025066-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/ce277adb715e/fnmol-15-1025066-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/fcafdce34d72/fnmol-15-1025066-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff77/9868638/02247c8410f5/fnmol-15-1025066-g0010.jpg

相似文献

[1]
Discovery of an evodiamine derivative for PI3K/AKT/GSK3β pathway activation and AD pathology improvement in mouse models.

Front Mol Neurosci. 2023-1-9

[2]
Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.

Exp Gerontol. 2016-11

[3]
Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.

J Pineal Res. 2015-5-12

[4]
Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice.

Metab Brain Dis. 2016-6

[5]
Evodiamine derivatives improve cognitive abilities in APP/PS1 transgenic mouse models of Alzheimer's disease.

Animal Model Exp Med. 2020-6-29

[6]
FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.

PLoS One. 2013-11-4

[7]
Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer's Disease.

Mol Neurobiol. 2017-11-23

[8]
Electroacupuncture Protects Cognition by Regulating Tau Phosphorylation and Glucose Metabolism via the AKT/GSK3β Signaling Pathway in Alzheimer's Disease Model Mice.

Front Neurosci. 2020-11-20

[9]
DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease.

Eur J Pharmacol. 2018-3-15

[10]
Cryptotanshinone Attenuates Amyloid-β-induced Tau Phosphorylation by Regulating PI3K/Akt/GSK3β Pathway in HT22 Cells.

Mol Neurobiol. 2022-7

引用本文的文献

[1]
Application of Natural Products in Neurodegenerative Diseases by Intranasal Administration: A Review.

Pharmaceutics. 2025-5-20

[2]
Exploring α-Syn's Functions Through Ablation Models: Physiological and Pathological Implications.

Cell Mol Neurobiol. 2025-5-19

[3]
Unravelling the role of protein kinase R (PKR) in neurodegenerative disease: a review.

Mol Biol Rep. 2025-4-9

[4]
Alkaloids as neuroprotectors: targeting signaling pathways in neurodegenerative diseases.

Mol Cell Biochem. 2025-4-7

[5]
Traditional Chinese Medicine-derived formulations and extracts modulating the PI3K/AKT pathway in Alzheimer's disease.

Front Pharmacol. 2025-3-17

[6]
Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer's Disease.

Cells. 2025-1-22

[7]
Evodiamine: A Extremely Potential Drug Development Candidate of Alkaloids from .

Int J Nanomedicine. 2024

[8]
Discovery of FO-4-15, a novel 1,2,4-oxadiazole derivative, ameliorates cognitive impairments in 3×Tg mice by activating the mGluR1/CaMKIIα pathway.

Acta Pharmacol Sin. 2025-1

[9]
Enhancing apoptosis-mediated anticancer activity of evodiamine through protein-based nanoparticles in breast cancer cells.

Sci Rep. 2024-1-31

[10]
Effect of berberine on cognitive function and β-amyloid precursor protein in Alzheimer's disease models: a systematic review and meta-analysis.

Front Pharmacol. 2024-1-16

本文引用的文献

[1]
Diallyl sulfide protects against dilated cardiomyopathy via inhibition of oxidative stress and apoptosis in mice.

Mol Med Rep. 2021-12

[2]
Insulin and Insulin Resistance in Alzheimer's Disease.

Int J Mol Sci. 2021-9-15

[3]
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration.

Mol Neurodegener. 2021-7-2

[4]
The Epidemiology of Alzheimer's Disease Modifiable Risk Factors and Prevention.

J Prev Alzheimers Dis. 2021

[5]
Neuroprotective Studies of Evodiamine in an Okadaic Acid-Induced Neurotoxicity.

Int J Mol Sci. 2021-5-19

[6]
CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy.

Nat Commun. 2021-2-9

[7]
Amentoflavone Ameliorates Memory Deficits and Abnormal Autophagy in Aβ-Induced Mice by mTOR Signaling.

Neurochem Res. 2021-4

[8]
Traditional Chinese medicine for anti-Alzheimer's disease: berberine and evodiamine from .

Chin Med. 2020-8-5

[9]
Genomic mechanisms in Alzheimer's disease.

Brain Pathol. 2020-9

[10]
Evodiamine derivatives improve cognitive abilities in APP/PS1 transgenic mouse models of Alzheimer's disease.

Animal Model Exp Med. 2020-6-29

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索